These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 38575370)

  • 21. Human leukocyte antigen epitope mismatch loads and the development of de novo donor-specific antibodies in cardiothoracic organ transplantation.
    Bedford A; Jervis S; Worthington J; Lowe M; Poulton K
    Int J Immunogenet; 2022 Feb; 49(1):30-38. PubMed ID: 34904369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HLA-DQ Mismatching and Kidney Transplant Outcomes.
    Leeaphorn N; Pena JRA; Thamcharoen N; Khankin EV; Pavlakis M; Cardarelli F
    Clin J Am Soc Nephrol; 2018 May; 13(5):763-771. PubMed ID: 29685925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody-Mediated Rejection Due to Donor-Specific HLA-DQB1 and DQA1 Antibodies After Kidney Transplantation: A Case Report.
    Thammanichanond D; Tammakorn C; Worawichawong S; Kantachuvesiri S
    Transplant Proc; 2020; 52(6):1931-1936. PubMed ID: 32444122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Donor selection in pediatric kidney transplantation using DR and DQ eplet mismatching: A new histocompatibility paradigm.
    Bryan CF; Chadha V; Warady BA
    Pediatr Transplant; 2016 Nov; 20(7):926-930. PubMed ID: 27448994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predicting Humoral Alloimmunity from Differences in Donor and Recipient HLA Surface Electrostatic Potential.
    Mallon DH; Kling C; Robb M; Ellinghaus E; Bradley JA; Taylor CJ; Kabelitz D; Kosmoliaptsis V
    J Immunol; 2018 Dec; 201(12):3780-3792. PubMed ID: 30429288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA epitope based matching for transplantation.
    Duquesnoy RJ
    Transpl Immunol; 2014 Jun; 31(1):1-6. PubMed ID: 24769079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epitope load identifies kidney transplant recipients at risk of allosensitization following minimization of immunosuppression.
    Snanoudj R; Kamar N; Cassuto E; Caillard S; Metzger M; Merville P; Thierry A; Jollet I; Grimbert P; Anglicheau D; Hazzan M; Choukroun G; Hurault De Ligny B; Janbon B; Vuiblet V; Devys A; Le Meur Y; Delahousse M; Morelon E; Bailly E; Girerd S; Amokrane K; Legendre C; Hertig A; Rondeau E; Taupin JL
    Kidney Int; 2019 Jun; 95(6):1471-1485. PubMed ID: 30955869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Donor-specific HLA-DQ antibodies may contribute to poor graft outcome after renal transplantation.
    DeVos JM; Gaber AO; Knight RJ; Land GA; Suki WN; Gaber LW; Patel SJ
    Kidney Int; 2012 Sep; 82(5):598-604. PubMed ID: 22622504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Humanized Mouse Model as a Novel Approach in the Assessment of Human Allogeneic Responses in Organ Transplantation.
    Ajith A; Mulloy LL; Musa MA; Bravo-Egana V; Horuzsko DD; Gani I; Horuzsko A
    Front Immunol; 2021; 12():687715. PubMed ID: 34177940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HLA Matching at the Eplet Level Protects Against Chronic Lung Allograft Dysfunction.
    Walton DC; Hiho SJ; Cantwell LS; Diviney MB; Wright ST; Snell GI; Paraskeva MA; Westall GP
    Am J Transplant; 2016 Sep; 16(9):2695-703. PubMed ID: 27002311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of Predicted HLA T-Cell Epitope Targets and T-Cell-Mediated Rejection After Kidney Transplantation.
    Senev A; Van Loon E; Lerut E; Coemans M; Callemeyn J; Daniëls L; Kerkhofs J; Koshy P; Kuypers D; Lamarthée B; Sprangers B; Tinel C; Van Craenenbroeck AH; Van Sandt V; Emonds MP; Naesens M
    Am J Kidney Dis; 2022 Dec; 80(6):718-729.e1. PubMed ID: 35690154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-human leukocyte antigen DQ antibodies in renal transplantation: Are we underestimating the most frequent donor specific alloantibodies?
    Carta P; Di Maria L; Caroti L; Buti E; Antognoli G; Minetti EE
    Transplant Rev (Orlando); 2015 Jul; 29(3):135-8. PubMed ID: 25976621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HLA-DQ Mismatches Lead to More Unacceptable Antigens, Greater Sensitization, and Increased Disparities in Repeat Transplant Candidates.
    Isaacson D; Schold JD; Gmeiner MW; Copley HC; Kosmoliaptsis V; Tambur AR
    J Am Soc Nephrol; 2022 Dec; 33(12):2293-2305. PubMed ID: 36450598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Second update of the International Registry of HLA Epitopes. I. The HLA-ABC Epitope Database.
    Duquesnoy RJ; Marrari M; Marroquim MS; Borges AG; da Mata Sousa LCD; Socorro A; do Monte SJH
    Hum Immunol; 2019 Feb; 80(2):103-106. PubMed ID: 30458204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HLA-DQ-Specific Recombinant Human Monoclonal Antibodies Allow for In-Depth Analysis of HLA-DQ Epitopes.
    Bezstarosti S; Kramer CSM; Franke-van Dijk MEI; Vergunst M; Bakker KH; Uyar-Mercankaya M; Buchli R; Roelen DL; de Fijter JW; Claas FHJ; Heidt S
    Front Immunol; 2021; 12():761893. PubMed ID: 35069533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical significance of low pre-transplant donor specific antibodies (DSA) in living donor kidney recipients with negative complement-dependent cytotoxicity crossmatches (CDCXM), and negative flow cytometry crossmatches (FLXM) - A single-center experience.
    Olszowska-Zaremba N; Gozdowska J; Zagożdżon R
    Transpl Immunol; 2022 Oct; 74():101672. PubMed ID: 35868613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. De novo DQ donor-specific antibodies are associated with a significant risk of antibody-mediated rejection and transplant glomerulopathy.
    Willicombe M; Brookes P; Sergeant R; Santos-Nunez E; Steggar C; Galliford J; McLean A; Cook TH; Cairns T; Roufosse C; Taube D
    Transplantation; 2012 Jul; 94(2):172-7. PubMed ID: 22735711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implementation of molecular matching in transplantation requires further characterization of both immunogenicity and antigenicity of individual HLA epitopes.
    Bezstarosti S; Kramer CSM; Claas FHJ; de Fijter JW; Reinders MEJ; Heidt S
    Hum Immunol; 2022 Mar; 83(3):256-263. PubMed ID: 34963506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA-EPI: A new EPIsode in exploring donor/recipient epitopic compatibilities.
    Geffard E; Boussamet L; Walencik A; Delbos F; Limou S; Gourraud PA; Vince N
    HLA; 2022 Feb; 99(2):79-92. PubMed ID: 34862850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA-DR and -DQ eplet mismatches and transplant glomerulopathy: a nested case-control study.
    Sapir-Pichhadze R; Tinckam K; Quach K; Logan AG; Laupacis A; John R; Beyene J; Kim SJ
    Am J Transplant; 2015 Jan; 15(1):137-48. PubMed ID: 25521856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.